JP2012070740A5 - - Google Patents

Download PDF

Info

Publication number
JP2012070740A5
JP2012070740A5 JP2011237542A JP2011237542A JP2012070740A5 JP 2012070740 A5 JP2012070740 A5 JP 2012070740A5 JP 2011237542 A JP2011237542 A JP 2011237542A JP 2011237542 A JP2011237542 A JP 2011237542A JP 2012070740 A5 JP2012070740 A5 JP 2012070740A5
Authority
JP
Japan
Prior art keywords
composition
medicament
sepsis
osteoarthritis
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011237542A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012070740A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012070740A publication Critical patent/JP2012070740A/ja
Publication of JP2012070740A5 publication Critical patent/JP2012070740A5/ja
Pending legal-status Critical Current

Links

JP2011237542A 2000-05-10 2011-10-28 哺乳動物レセプタータンパク質；関連する試薬および方法 Pending JP2012070740A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20342600P 2000-05-10 2000-05-10
US60/203,426 2000-05-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008104044A Division JP2008273961A (ja) 2000-05-10 2008-04-11 哺乳動物レセプタータンパク質；関連する試薬および方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014254055A Division JP2015110576A (ja) 2000-05-10 2014-12-16 哺乳動物レセプタータンパク質；関連する試薬および方法

Publications (2)

Publication Number Publication Date
JP2012070740A JP2012070740A (ja) 2012-04-12
JP2012070740A5 true JP2012070740A5 (https=) 2012-07-12

Family

ID=22753958

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2001582389A Expired - Fee Related JP5073909B2 (ja) 2000-05-10 2001-05-10 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2008104044A Withdrawn JP2008273961A (ja) 2000-05-10 2008-04-11 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2011237542A Pending JP2012070740A (ja) 2000-05-10 2011-10-28 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2012118337A Pending JP2012187111A (ja) 2000-05-10 2012-05-24 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2014210974A Pending JP2015057396A (ja) 2000-05-10 2014-10-15 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2014254055A Withdrawn JP2015110576A (ja) 2000-05-10 2014-12-16 哺乳動物レセプタータンパク質；関連する試薬および方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2001582389A Expired - Fee Related JP5073909B2 (ja) 2000-05-10 2001-05-10 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2008104044A Withdrawn JP2008273961A (ja) 2000-05-10 2008-04-11 哺乳動物レセプタータンパク質；関連する試薬および方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2012118337A Pending JP2012187111A (ja) 2000-05-10 2012-05-24 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2014210974A Pending JP2015057396A (ja) 2000-05-10 2014-10-15 哺乳動物レセプタータンパク質；関連する試薬および方法
JP2014254055A Withdrawn JP2015110576A (ja) 2000-05-10 2014-12-16 哺乳動物レセプタータンパク質；関連する試薬および方法

Country Status (25)

Country Link
US (7) US6756481B2 (https=)
EP (3) EP1287130B2 (https=)
JP (6) JP5073909B2 (https=)
KR (1) KR100869621B1 (https=)
CN (2) CN1575337A (https=)
AT (1) ATE396264T1 (https=)
AU (2) AU2001261351B2 (https=)
CA (1) CA2408571C (https=)
CY (1) CY1108545T1 (https=)
CZ (1) CZ304022B6 (https=)
DE (1) DE60134136D1 (https=)
DK (1) DK1287130T3 (https=)
ES (1) ES2307618T3 (https=)
HK (1) HK1049862B (https=)
HU (1) HUP0302339A3 (https=)
IL (2) IL152414A0 (https=)
MX (1) MXPA02011081A (https=)
NO (2) NO331408B1 (https=)
NZ (1) NZ522146A (https=)
PL (1) PL209128B1 (https=)
PT (1) PT1287130E (https=)
SI (1) SI1287130T1 (https=)
SK (1) SK287984B6 (https=)
WO (1) WO2001085790A2 (https=)
ZA (1) ZA200208795B (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082734A1 (en) * 1999-06-01 2003-05-01 Dowling Lynette M. Mammalian receptor proteins; related reagents and methods
EP2325316B8 (en) * 1999-06-02 2017-04-19 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, NR10
AU7445900A (en) * 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
US7422743B2 (en) 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
US6756481B2 (en) * 2000-05-10 2004-06-29 Schering Corporation IL-23 receptor binding compositions
WO2004042009A2 (en) * 2002-10-30 2004-05-21 Genentech, Inc. Inhibition of il-17 production
WO2004058178A2 (en) 2002-12-23 2004-07-15 Schering Corporation Uses of mammalian cytokine; related reagents
US20040219150A1 (en) * 2003-02-06 2004-11-04 Cua Daniel J. Uses of mammalian cytokine; related reagents
US7282204B2 (en) * 2003-03-10 2007-10-16 Schering Corporation Uses of IL-23 agonists and antagonists; related reagents
CN101052726A (zh) 2003-05-09 2007-10-10 森托科尔公司 IL－23p40特异性免疫球蛋白衍生蛋白、组合物、方法和用途
CN1942201B (zh) * 2004-02-17 2012-06-20 先灵公司 调节il-23活性的方法；相关试剂
BRPI0510617A (pt) 2004-05-03 2007-10-30 Schering Corp uso de expressão de il-17 para prever inflamação de pele; processos de tratamento
US20050287593A1 (en) * 2004-05-03 2005-12-29 Schering Corporation Use of cytokine expression to predict skin inflammation; methods of treatment
AR051444A1 (es) * 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
US7820168B2 (en) * 2004-12-20 2010-10-26 Schering Corporation Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17
SI2452694T1 (sl) 2005-06-30 2019-05-31 Janssen Biotech, Inc. Protitelesa proti-IL-23, sestavki in postopki uporabe
HUE034269T2 (en) 2005-12-29 2018-02-28 Janssen Biotech Inc Human anti-IL-23 antibodies, preparations, methods and applications
ES2429407T3 (es) 2006-06-08 2013-11-14 Chugai Seiyaku Kabushiki Kaisha Agente preventivo o remedio para enfermedades inflamatorias
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
CA2679400A1 (en) * 2007-02-28 2008-09-04 Schering Corporation Combination therapy for treatment of immune disorders
NZ579251A (en) 2007-02-28 2012-06-29 Schering Corp Engineered anti-il-23r antibodies
CA2708065C (en) 2007-12-05 2015-02-24 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for pruritus
RU2474588C2 (ru) 2008-05-05 2013-02-10 Новиммун Са Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
US20110158992A1 (en) * 2008-08-27 2011-06-30 Schering Corporation Engineered Anti-IL-23R Antibodies
JP2012524524A (ja) * 2009-04-27 2012-10-18 ノバルティス アーゲー ＩＬ−１２レセプターβ１サブユニットに特異的な治療用抗体の組成物および使用方法
CN102458437B (zh) 2009-05-05 2015-06-10 诺维莫尼公司 抗il-17f抗体及其使用方法
MX2019000046A (es) 2010-11-04 2023-10-05 Boehringer Ingelheim Int Anticuerpos anti-il-23.
PL3326649T3 (pl) 2012-05-03 2022-04-25 Boehringer Ingelheim International Gmbh Przeciwciała anty-il-23p19
EP3708679A1 (en) 2014-07-24 2020-09-16 Boehringer Ingelheim International GmbH Biomarkers useful in the treatment of il-23a related diseases
EA202193002A2 (ru) 2014-09-03 2022-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Соединение, нацеленное на ил-23a и фно-альфа, и его применение
AU2016215535B2 (en) 2015-02-04 2021-09-16 Boehringer Ingelheim International Gmbh Methods of treating inflammatory diseases
MX2020009265A (es) 2018-03-05 2020-10-01 Janssen Biotech Inc Metodos para tratar la enfermedad de crohn con un anticuerpo especifico anti-il23.
IL283192B2 (en) 2018-11-20 2025-10-01 Janssen Biotech Inc A safe and effective method for treating psoriasis with a specific anti-IL-23 antibody
US12589132B2 (en) 2019-02-22 2026-03-31 Five Prime Therapeutics, Inc. CD80 extracellular domain Fc fusion proteins for treating PD-L1 negative tumors
JP7805788B2 (ja) 2019-05-23 2026-01-26 ヤンセン バイオテツク，インコーポレーテツド Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
TW202535466A (zh) 2019-09-09 2025-09-16 德商百靈佳殷格翰國際股份有限公司 抗-il-23p19抗體調配物
IL298389A (en) 2020-05-21 2023-01-01 Janssen Biotech Inc Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2046920B1 (https=) 1969-06-19 1974-05-03 Citizen Watch Co Ltd
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
US5888774A (en) 1994-12-19 1999-03-30 Cangene Corporation Recombinant DNA molecules and expression vectors for erythropoietin
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
JPH11273358A (ja) 1998-03-26 1999-10-08 Kawasaki Steel Corp 半導体記憶装置
PT1181366E (pt) * 1999-06-01 2009-05-25 Schering Corp Proteínas receptoras de mamífero; reagentes e métodos relacionados
US20030082734A1 (en) 1999-06-01 2003-05-01 Dowling Lynette M. Mammalian receptor proteins; related reagents and methods
AU780163B2 (en) * 1999-09-09 2005-03-03 Merck Sharp & Dohme Corp. Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
AU7445900A (en) * 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
JP2008099690A (ja) 1999-09-27 2008-05-01 Chugai Pharmaceut Co Ltd 新規ヘモポエチン受容体蛋白質、ｎｒ１２
US6756481B2 (en) * 2000-05-10 2004-06-29 Schering Corporation IL-23 receptor binding compositions

Similar Documents

Publication Publication Date Title
JP2012070740A5 (https=)
Michels da Silva et al. Inflammatory and molecular pathways in heart failure—ischemia, HFpEF and transthyretin cardiac amyloidosis
Baci et al. Innate immunity effector cells as inflammatory drivers of cardiac fibrosis
JP2010166916A5 (https=)
JP2012021001A5 (https=)
JP2017079785A5 (https=)
JP2014076062A5 (https=)
JP2011157378A5 (https=)
Kurschus et al. IL-17 for therapy
US20140213772A1 (en) Cross-over dual variable domain immunoglobulin constructs
JP2013107899A5 (https=)
JP2015007098A5 (https=)
JP2013537418A5 (https=)
JP2011184466A5 (https=)
JP2015525230A5 (https=)
JP2012517818A5 (https=)
JP2017522903A5 (https=)
JP2017029157A5 (https=)
JP2015131795A5 (https=)
JP2008525033A5 (https=)
JP2016524592A5 (https=)
JP2014519524A5 (https=)
HRP20150799T1 (hr) Sastavi i postupci za protutijela protiv komplementnog proteina c5
UA116194C2 (uk) Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном
JP2010526153A5 (https=)